In the context of the immune landscape, data from pancreatic cancer suggests that high tumor infiltration of CD4+ and CD8+ T cells, low Tregs, and a high M1/M2 macrophage ratio are all associated with improved survival in pancreatic cancer [39]. This evidence concerns the gene CD8A and neoplasm.